Biodegradable Stents Market - Size & Upcoming Industry Trends (2024-2032)

Biodegradable Stents Market Synopsis:

Biodegradable Stents Market Size Was Valued at USD 0.35 Billion in 2023, and is Projected to Reach USD 0.68 Billion by 2032, Growing at a CAGR of 7.80% From 2024-2032.

Biodegradable stents are being developed as new generation device for the treatment of obstructed blood vessels or any other tubular structure in the body. Unline self-expandable metallic stents which may trigger long term side effects that may include chronic inflammation or restenosis, biodegradable stents are appropriately designed to self-dissolve after sometime. They are basically constructed from polymers or biodegradable metals which after serving their intended utility are incorporated into tissues of the body. These stents are most often inserted in situations where the patient has coronary artery disease or peripheral artery disease, and allow for propping open of blood vessels, while serving a short-term purpose and minimizing long-term negative effects on the patient’s health.

Growth in the number of biodegradable stents market is majorly triggered by the rising incidence of cardiovascular diseases all across the world. Increased sedentary lifestyles, bad diets, and increasing obesity levels are putting pressure on the rates of CAD, which demands more stent procedures among them. Biodegradable stents are preferred as it doesn’t require long-term implant which sometimes cause issues like stent thrombosis, irritation of vessel. Besides, the increased social rate of elderly people, who are in higher risk for cardiovascular diseases, enhances the market progression.

Other causes include technology relating to the stent where improvements in designs and materials have been realized. Continued advancements of new biodegradable polymers and metals have made these devices safer and more effective. Furthermore, more studies and experiences in clinical practice have shown that biodegradable stents should be preferred due to the reduction of restenosis compared to metal stents and that such stents are beneficial to use in clinical trials. There are various funding and support by government towards the health care infrastructures also boosts the use of biodegradable stents in different parts.

Biodegradable Stents Market Trend Analysis:

The shift towards personalized medicine

• Another major factor affecting the biodegradable stents market is differentiated treatment wherein the method of stent creation and implantation depends on the patient’s peculiarities. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are the imaging techniques that provide better means of stent deliveries and better patients’ prognosis. Like patient customization, stents that reflect the vascular patterns of the individual patients are becoming ideal, meaning right treatment is right on the way.
• A trend observed in the current market is the shift of emphasis being placed on minimizing procedural costs. Health care institutions are currently operating on limited funds in many parts of the world, thus creating a strong need for measures that will enable the provision of superior quality services at a lesser cost. Biodegradable stents by avoiding the follow up procedures also in the long run help reduce the cost of treatment. In the future, the market for biodegradable stent products will continue to grow as new models of these products are designed to be more affordable and receive approval to begin replacing other metal stents used in these markets.

Rise in healthcare spending, with increasing government initiatives to improve healthcare infrastructure.

• The Asia-Pacific area is considered to be a promising region for the biodegradable stents market to make new developments. The region is witnessing growth in the healthcare sector and government involvement towards betterment of the health care in sectors like China, India, Japan and other countries. Epidemiological transition and increased prevalence of cardiovascular diseases in these countries along with increasing middle-class populace having better healthcare access to the advanced treatment like biodegradable stents. This situation opens up a big opportunity for manufacturers to increase their market share in the region.
• Another opportunity is that of designing environmentally friendly stents for nonvascular uses including urological, gastrointestinal and biliary use. Possible, as the range of biodegradable material research increases these stents may be applicable to other areas of therapy. One of the opportunities that are indicative in the market growth and further development is that biodegradable stents are able to minimize the long-term negative outcomes in such treatments and as the usage of minimally invasive interventions continues to expand, this segment can enjoy a rather high market potential.

Biodegradable Stents Market Segment Analysis:

Biodegradable Stents Market is Segmented on the basis of Product Type, Material, Application, End User, and Region

By Product Type, Coronary Stents segment is expected to dominate the market during the forecast period

• Biodegradable stents are of different types depending on their use as follows- Coronary stents are inserted to relieve narrowing in the arteries which supplies blood to the heart’s muscles in patients with coronary artery diseases. Peripheral stents were created to expand blood vessels not located in the heart but rather they are used in treatment of peripheral arterial disease with specific emphasis on the limbs; legs and arms. Ureteral stents are the instrumental tubes, which are inserted in the ureters to avoid or treat the conditions which cause blockage of urine transport from the kidneys to the bladder. Self-expandable biliary stents are applied for draining affection in the bile ducts due to such diseases as cholelithiasis or neoplasms. Intestinal stents are implanted inside a patient’s gastrointestinal tract to resolve obstructions or narrowing’s to facilitate digestion and defecation. Both shaft types of stents can be used for each kind of medical application, taking into consideration the specificities of the organs and vessels.

By Application, Coronary Artery Disease segment expected to held the largest share

• The stent that is biodegradable comes into application by being used to treat both coronary artery diseases and peripheral artery diseases. Coronary artery disease known as CAD for short, is a ailment whereby the blood vessels that supply blood to the heart muscle (coronary arteries) become narrow, or blocked by the formation of plaques. These are deployed to hold the lumens of these arteries open, thus increasing blood supply and minimize incidents of heart attack. However, Peripheral artery disease also known as peripheral arterial disease, impacts blood vessels located outside the heart, particularly those in the legs. Self-degradable stents are inserted into these peripheral arteries to unblock it and to ensure that there isn’t occurrence of issues like lowered blood flow to arms or legs or development of ulcers. Despite this, both applications serve the purpose of addressing patients’ needs temporarily in order to eliminate longstanding side effects of permanent stents.

Biodegradable Stents Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America has captured highest percentage of the biodegradable stents market share and contributes a fifth of the total market. This dominance is primarily ascribed to the fact that there is a strong healthcare system in this region and thus there is easy dissemination of newly developed technologies in healthcare delivery. Their high incidence in the United States, in particular, drives the need for new therapies such as biodegradable stents. Also, the medical device market in North America is well developed and has players that are developing resources in the improvement of biodegradable stents’ technology.
• Moreover, a more positive reimbursement structure and rising appreciation for biodegradable stents by the healthcare community have made the market even more robust in North America. There are currently numerous biodegradable stent products, for which regulatory authorities like the US Food and Drug Administration (FDA) have cleared that they can be commercialised quickly and made available in clinical practice. Such increases the concern for patient’s outcome through the introduction of emergent medical products, and technologies, further propelling the region to lead in the global biodegradable stents market.

Active Key Players in the Biodegradable Stents Market:

• Abbott Laboratories (United States)
• BIOTRONIK SE & Co. KG (Germany)
• Boston Scientific Corporation (United States)
• Elixir Medical Corporation (United States)
• Terumo Corporation (Japan)
• Arterius Limited (United Kingdom)
• Kyoto Medical Planning Co., Ltd. (Japan)
• Reva Medical, LLC (United States)
• S3V Vascular Technologies (India)
• B. Braun Melsungen AG (Germany)
• Other Active Players